Targeting Outflow Facility in Glaucoma Management
Author:
- 1 April 2003
- journal article
- review article
- Published by Elsevier in Survey of Ophthalmology
- Vol. 48 (2) , S17-S20
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Reduction of Intraocular Pressure and Glaucoma ProgressionArchives of Ophthalmology (1950), 2002
- Effects of latanoprost and unoprostone when used alone or in combination for open-angle glaucomaAmerican Journal of Ophthalmology, 2001
- Measurement of Uveoscleral Outflow in HumansJournal of Glaucoma, 2001
- Mechanism of Action of Bimatoprost (Lumigan™)Survey of Ophthalmology, 2001
- Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamicsAmerican Journal of Ophthalmology, 2001
- Large Diurnal Fluctuations in Intraocular Pressure Are an Independent Risk Factor in Patients With GlaucomaJournal of Glaucoma, 2000
- Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patientsAmerican Journal of Ophthalmology, 1999
- Effects of PhXA41, A New Prostaglandin F2α Analog, on Aqueous Humor Dynamics in Human EyesOphthalmology, 1993
- Aqueous Flow is Reduced by the Alpha-adrenergic Agonist, Apraclonidine Hydrochloride (ALO 2145)Ophthalmology, 1988
- CLINICAL MEASUREMENTS OF AQUEOUS OUTFLOWArchives of Ophthalmology (1950), 1951